Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Comparison of antibody responses and parasite clearance in artemisinin therapeutic efficacy studies in Democratic Republic of Congo and Asia.

Cutts JC. et al, (2022), The Journal of infectious diseases

Anti-Gametocyte Antigen Humoral Immunity and Gametocytemia During Treatment of Uncomplicated Falciparum Malaria: A Multi-National Study.

O'Flaherty K. et al, (2022), Frontiers in cellular and infection microbiology, 12

The cardiovascular effects of amodiaquine and structurally related antimalarials: An individual patient data meta-analysis

Chan XHS. et al, (2021), PLOS Medicine, 18, e1003766 - e1003766

Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination

Jacob CG. et al, (2021), eLife, 10

An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples

Ahouidi A. et al, (2021), Wellcome Open Research, 6, 42 - 42

Pharmacokinetic Study of Rectal Artesunate in Children with Severe Malaria in Africa

Fanello C. et al, (2021), Antimicrobial Agents and Chemotherapy, 65

An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples

Ahouidi A. et al, (2021), Wellcome Open Research, 6, 42 - 42

Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial

van der Pluijm RW. et al, (2020), The Lancet, 395, 1345 - 1360

A Randomized Controlled Trial of Three- versus Five-Day Artemether-Lumefantrine Regimens for Treatment of Uncomplicated Plasmodium falciparum Malaria in Pregnancy in Africa

Onyamboko MA. et al, (2020), Antimicrobial Agents and Chemotherapy, 64

Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments—a WWARN individual patient data meta-analysis

(2019), BMC Medicine, 17

Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis

(2019), Malaria Journal, 18

Genomic structure and diversity of Plasmodium falciparum in Southeast Asia reveal recent parasite migration patterns

Shetty AC. et al, (2019), Nature Communications, 10

Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria

Intharabut B. et al, (2019), The Journal of Infectious Diseases, 219, 1483 - 1489

Defining System Requirements for Simplified Blood Culture to Enable Widespread Use in Resource-Limited Settings

Dailey P. et al, (2019), Diagnostics, 9, 10 - 10

Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria – a proposed model-derived age-based regimen for sub-Saharan Africa

Taylor WR. et al, (2018), BMC Medicine, 16

Post-treatment haemolysis in African children with hyperparasitaemic falciparum malaria; a randomized comparison of artesunate and quinine

Fanello C. et al, (2017), BMC Infectious Diseases, 17

Pfhrp2 Deletions in the Democratic Republic of Congo: Evidence of Absence, or Absence of Evidence?

Woodrow CJ. and Fanello C., (2017), The Journal of Infectious Diseases, 216, 504 - 506

Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria

Jeeyapant A. et al, (2017), PLOS ONE, 12, e0169307 - e0169307

Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data

(2016), BMC Medicine, 14

Genomic epidemiology of artemisinin resistant malaria

(2016), eLife, 5

Load More

Include forthcoming?